{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T12:40:47Z","timestamp":1772800847199,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T00:00:00Z","timestamp":1532908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1208\/s12249-018-1127-8","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T18:30:30Z","timestamp":1532975430000},"page":"3009-3018","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Morphological, Stability, and Hypoglycemic Effects of New Gliclazide-Bile Acid Microcapsules for Type 1 Diabetes Treatment: the Microencapsulation of Anti-diabetics Using a Microcapsule-Stabilizing Bile Acid"],"prefix":"10.1208","volume":"19","author":[{"given":"Sangeetha","family":"Mathavan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel","family":"Chen-Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Arfuso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hani","family":"Al-Salami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,30]]},"reference":[{"key":"1127_CR1","unstructured":"JDRF (2014) http:\/\/jdrf.org\/about-jdrf\/fact-sheets\/ ."},{"issue":"1","key":"1127_CR2","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1172\/JCI44339","volume":"121","author":"JL Gaglia","year":"2011","unstructured":"Gaglia JL, Guimaraes AR, Harisinghani M, Turvey SE, Jackson R, Benoist C, et al. Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients. J Clin Invest. 2011;121(1):442\u20135.","journal-title":"J Clin Invest"},{"issue":"7","key":"1127_CR3","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.2967\/jnumed.109.074294","volume":"51","author":"Z Rabkin","year":"2010","unstructured":"Rabkin Z, Israel O, Keidar Z. Do hyperglycemia and diabetes affect the incidence of false-negative 18F-FDG PET\/CT studies in patients evaluated for infection or inflammation and cancer? A comparative analysis. J Nucl Med. 2010;51(7):1015\u201320.","journal-title":"J Nucl Med"},{"issue":"8","key":"1127_CR4","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3109\/02652048.2011.586068","volume":"28","author":"M Whelehan","year":"2011","unstructured":"Whelehan M, Marison IW. Microencapsulation using vibrating technology. J Microencapsul. 2011;28(8):669\u201388.","journal-title":"J Microencapsul"},{"issue":"6","key":"1127_CR5","doi-asserted-by":"publisher","first-page":"702","DOI":"10.3109\/10837450.2014.915570","volume":"20","author":"A Mooranian","year":"2015","unstructured":"Mooranian A, Negrulj R, Mathavan S, Martinez J, Sciarretta J, Chen-Tan N, et al. An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations. Pharm Dev Technol. 2015;20(6):702\u20139.","journal-title":"Pharm Dev Technol"},{"issue":"1","key":"1127_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1463-1326.2006.00571.x","volume":"9","author":"A Rakel","year":"2007","unstructured":"Rakel A, Renier G, Roussin A, Buithieu J, Mamputu JC, Serri O. Beneficial effects of gliclazide modified release compared with glibenclamide on endothelial activation and low-grade inflammation in patients with type 2 diabetes. Diabetes Obes Metab. 2007;9(1):127\u20139.","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"1127_CR7","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.3109\/10717544.2015.1110846","volume":"23","author":"S Mathavan","year":"2016","unstructured":"Mathavan S, Chen-Tan N, Arfuso F, Al-Salami H. A comprehensive study of novel microcapsules incorporating gliclazide and a permeation enhancing bile acid: hypoglycemic effect in an animal model of Type-1 diabetes. Drug Deliv. 2016;23(8):2869\u201380.","journal-title":"Drug Deliv"},{"issue":"6","key":"1127_CR8","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3109\/21691401.2015.1058807","volume":"44","author":"S Mathavan","year":"2016","unstructured":"Mathavan S, Chen-Tan N, Arfuso F, Al-Salami H. The role of the bile acid chenodeoxycholic acid in the targeted oral delivery of the anti-diabetic drug gliclazide, and its applications in type 1 diabetes. Artif Cells Nanomed Biotechnol. 2016;44(6):1508\u201319.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"4","key":"1127_CR9","first-page":"532","volume":"60","author":"H Al-Salami","year":"2008","unstructured":"Al-Salami H, Butt G, Tucker I, Mikov M. Influence of the semisynthetic bile acid (MKC) on the ileal permeation of gliclazide in healthy and diabetic rats. Pharmacol Rep. 2008;60(4):532\u201341.","journal-title":"Pharmacol Rep"},{"issue":"1","key":"1127_CR10","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0168-8278(01)00092-7","volume":"35","author":"KN Lazaridis","year":"2001","unstructured":"Lazaridis KN, Gores GJ, Lindor KD. Ursodeoxycholic acid \u2018mechanisms of action and clinical use in hepatobiliary disorders\u2019. J Hepatol. 2001;35(1):134\u201346.","journal-title":"J Hepatol"},{"issue":"3","key":"1127_CR11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1053\/jhep.2002.36088","volume":"36","author":"G Paumgartner","year":"2002","unstructured":"Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology. 2002;36(3):525\u201331.","journal-title":"Hepatology"},{"issue":"2","key":"1127_CR12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1872-034X.2007.00297.x","volume":"38","author":"T Ikegami","year":"2008","unstructured":"Ikegami T, Matsuzaki Y. Ursodeoxycholic acid: mechanism of action and novel clinical applications. Hepatol Res. 2008;38(2):123\u201331.","journal-title":"Hepatol Res"},{"issue":"1","key":"1127_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1440-1746.2001.02376.x","volume":"16","author":"D Kumar","year":"2001","unstructured":"Kumar D, Tandon RK. Use of ursodeoxycholic acid in liver diseases. J Gastroenterol Hepatol. 2001;16(1):3\u201314.","journal-title":"J Gastroenterol Hepatol"},{"issue":"211","key":"1127_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3006534","volume":"5","author":"F Engin","year":"2013","unstructured":"Engin F, Yermalovich A, Nguyen T, Hummasti S, Fu W, Eizirik DL, et al. Restoration of the unfolded protein response in pancreatic \u03b2 cells protects mice against type 1 diabetes. Sci Transl Med. 2013;5(211):211ra156.","journal-title":"Sci Transl Med"},{"issue":"2","key":"1127_CR15","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3109\/21691401.2014.971806","volume":"44","author":"A Mooranian","year":"2016","unstructured":"Mooranian A, Negrulj R, Chen-Tan N, Fakhoury M, Arfuso F, Jones F, et al. Advanced bile acid-based multi-compartmental microencapsulated pancreatic \u03b2-cells integrating a polyelectrolyte-bile acid formulation, for diabetes treatment. Artif Cells Nanomed Biotechnol. 2016;44(2):588\u201395.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"2","key":"1127_CR16","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s12247-014-9182-5","volume":"9","author":"A Mooranian","year":"2014","unstructured":"Mooranian A, Negrulj R, Mathavan S, Martinez J, Sciarretta J, Chen-Tan N, et al. Stability and release kinetics of an advanced gliclazide-cholic acid formulation: the use of artificial-cell microencapsulation in slow release targeted oral delivery of antidiabetics. J Pharm Innov. 2014;9(2):150\u20137.","journal-title":"J Pharm Innov"},{"key":"1127_CR17","first-page":"1673","volume":"8","author":"A Mooranian","year":"2014","unstructured":"Mooranian A, Negrulj R, Chen-Tan N, Watts GF, Arfuso F, Al-Salami H. An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer. Drug Des Devel Ther. 2014;8:1673\u201383.","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"1127_CR18","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3109\/03639045.2012.681383","volume":"39","author":"NS Barakat","year":"2013","unstructured":"Barakat NS, Shazly GA, Almedany AH. Influence of polymer blends on the characterization of gliclazide\u2014encapsulated into poly (epsilon-caprolactone) microparticles. Drug Dev Ind Pharm. 2013;39(2):352\u201362.","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"1127_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0928-4931(00)00177-6","volume":"13","author":"YJ Wang","year":"2000","unstructured":"Wang YJ. Development of new polycations for cell encapsulation with alginate. Mater Sci Eng C. 2000;13(1):59\u201363.","journal-title":"Mater Sci Eng C"},{"issue":"5","key":"1127_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/bdd.550","volume":"28","author":"V Stetinova","year":"2007","unstructured":"Stetinova V, Kvetina J, Pastera J, Polaskova A, Prazakova M. Gliclazide: pharmacokinetic-pharmacodynamic relationships in rats. Biopharm Drug Dispos. 2007;28(5):241\u20138.","journal-title":"Biopharm Drug Dispos"},{"issue":"3","key":"1127_CR21","first-page":"191","volume":"14","author":"R Korec","year":"1980","unstructured":"Korec R. Treatment of alloxan and streptozotocin diabetes in rats by intrafamiliar homo (allo) transplantation of neonatal pancreases. Endocrinol Exp. 1980;14(3):191\u20138.","journal-title":"Endocrinol Exp"},{"issue":"SPE","key":"1127_CR22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1590\/S0102-86502003001100009","volume":"18","author":"EN Carvalho","year":"2003","unstructured":"Carvalho EN, Carvalho NA, Ferreira LM. Experimental model of induction of diabetes mellitus in rats. Acta Cirurgica Brasileira. 2003;18(SPE):60\u20134.","journal-title":"Acta Cirurgica Brasileira"},{"issue":"2","key":"1127_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s13318-011-0060-y","volume":"37","author":"H Al-Salami","year":"2012","unstructured":"Al-Salami H, Butt G, Tucker I, Golocorbin-Kon S, Mikov M. Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats. Eur J Drug Metab Pharmacokinet. 2012;37(2):99\u2013108.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"9","key":"1127_CR24","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/clinchem\/17.9.915","volume":"17","author":"MJ Alam","year":"1971","unstructured":"Alam MJ, Rahman MA. Changes in the saccharoid fraction in rats with alloxan-induced diabetes or injected with epinephrine. Clin Chem. 1971;17(9):915\u201320.","journal-title":"Clin Chem"},{"issue":"1\u20133","key":"1127_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0001-8686(03)00105-2","volume":"106","author":"R Greenwood","year":"2003","unstructured":"Greenwood R. Review of the measurement of zeta potentials in concentrated aqueous suspensions using electroacoustics. Adv Colloid Interf Sci. 2003;106(1\u20133):55\u201381.","journal-title":"Adv Colloid Interf Sci"},{"key":"1127_CR26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1504\/IJNBM.2016.079684","volume":"6","author":"A Mooranian","year":"2016","unstructured":"Mooranian A, Negrulj R, Al-Salami H. Viability and topographical analysis of microencapsulated \u03b2-cells exposed to a biotransformed tertiary bile acid: an ex vivo study. Int J Nano Biomaterials. 2016;6:74.","journal-title":"Int J Nano Biomaterials"},{"issue":"6","key":"1127_CR27","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/02652048.2016.1228703","volume":"33","author":"A Mooranian","year":"2016","unstructured":"Mooranian A, Negrulj R, Al-Salami H. The impact of allylamine-bile acid combinations on cell delivery microcapsules in diabetes. J Microencapsul. 2016;33(6):569\u201374.","journal-title":"J Microencapsul"},{"issue":"3","key":"1127_CR28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4155\/tde-2015-0001","volume":"7","author":"A Mooranian","year":"2016","unstructured":"Mooranian A, Negrulj R, Al-Salami H. Flow vibration-doubled concentric system coupled with low ratio amine to produce bile acid-macrocapsules of beta-cells. Ther Deliv. 2016;7(3):171\u20138.","journal-title":"Ther Deliv"},{"issue":"4","key":"1127_CR29","first-page":"167","volume":"21","author":"P Gill","year":"2010","unstructured":"Gill P, Moghadam TT, Ranjbar B. Differential scanning calorimetry techniques: applications in biology and nanoscience. J Biomol Tech. 2010;21(4):167\u201393.","journal-title":"J Biomol Tech"},{"issue":"1","key":"1127_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.carbpol.2006.02.008","volume":"66","author":"B Sarmento","year":"2006","unstructured":"Sarmento B, Ferreira D, Veiga F, Ribeiro A. Characterization of insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studies. Carbohydr Polym. 2006;66(1):1\u20137.","journal-title":"Carbohydr Polym"},{"issue":"2","key":"1127_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1205\/fbp.04399","volume":"83","author":"SG Kazarian","year":"2005","unstructured":"Kazarian SG, Kong KWT, Bajomo M, Van Der Weerd J, Chan KLA. Spectroscopic imaging applied to drug release. Food Bioprod Process. 2005;83(2):127\u201335.","journal-title":"Food Bioprod Process"},{"issue":"2","key":"1127_CR32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.2042-7158.2010.01214.x","volume":"63","author":"NS Barakat","year":"2011","unstructured":"Barakat NS, Almurshedi AS. Design and development of gliclazide-loaded chitosan microparticles for oral sustained drug delivery: in-vitro\/in-vivo evaluation. J Pharm Pharmacol. 2011;63(2):169\u201378.","journal-title":"J Pharm Pharmacol"},{"issue":"4","key":"1127_CR33","doi-asserted-by":"publisher","first-page":"841","DOI":"10.4314\/tjpr.v6i4.14668","volume":"6","author":"K Prakash","year":"2007","unstructured":"Prakash K, Raju P, Shanta K, Lakshmi M. Preparation and characterization of lamivudine microcapsules using various cellulose polymers. Trop J Pharm Res. 2007;6(4):841\u20137.","journal-title":"Trop J Pharm Res"},{"issue":"1","key":"1127_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0032-3861(96)00458-2","volume":"38","author":"C Sartori","year":"1997","unstructured":"Sartori C, Finch DS, Ralph B, Gilding K. Determination of the cation content of alginate thin films by FTi.R. Spectroscopy. Polymer. 1997;38(1):43\u201351.","journal-title":"Polymer"},{"issue":"4\u20135","key":"1127_CR35","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.saa.2005.04.027","volume":"62","author":"L Yang","year":"2005","unstructured":"Yang L, Xu Y, Su Y, Wu J, Zhao K, Chen J, et al. FTIR spectroscopic study on the variations of molecular structures of some carboxyl acids induced by free electron laser. Spectrochim Acta A Mol Biomol Spectrosc. 2005;62(4\u20135):1209\u201315.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"issue":"1","key":"1127_CR36","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1208\/s12249-008-9041-0","volume":"9","author":"SK Prajapati","year":"2008","unstructured":"Prajapati SK, Tripathi P, Ubaidulla U, Anand V. Design and development of gliclazide mucoadhesive microcapsules: in vitro and in vivo evaluation. AAPS PharmSciTech. 2008;9(1):224\u201330.","journal-title":"AAPS PharmSciTech"},{"key":"1127_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ijbiomac.2012.12.033","volume":"55","author":"VD Prajapati","year":"2013","unstructured":"Prajapati VD, Mashru KH, Solanki HK, Jani GK. Development of modified release gliclazide biological macromolecules using natural biodegradable polymers. Int J Biol Macromol. 2013;55:6\u201314.","journal-title":"Int J Biol Macromol"},{"issue":"1\u20132","key":"1127_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijpharm.2006.05.054","volume":"323","author":"G Pasparakis","year":"2006","unstructured":"Pasparakis G, Bouropoulos N. Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate-chitosan beads. Int J Pharm. 2006;323(1\u20132):34\u201342.","journal-title":"Int J Pharm"},{"issue":"1","key":"1127_CR39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2174\/1573399812666151229101756","volume":"13","author":"A Mooranian","year":"2017","unstructured":"Mooranian A, Negrulj R, Al-Salami H. The effects of ionic gelation-vibrational jet flow technique in fabrication of microcapsules incorporating \u03b2-cell: applications in diabetes. Curr Diabetes Rev. 2017;13(1):91\u20136.","journal-title":"Curr Diabetes Rev"},{"issue":"2","key":"1127_CR40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s12668-016-0198-9","volume":"6","author":"A Mooranian","year":"2016","unstructured":"Mooranian A, Negrulj R, Al-Salami H. Primary bile acid chenodeoxycholic acid-based microcapsules to examine beta-cell survival and the inflammatory response. Bionanoscience. 2016;6(2):103\u20139.","journal-title":"Bionanoscience"},{"issue":"5","key":"1127_CR41","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1007\/s11095-016-1863-y","volume":"33","author":"A Mooranian","year":"2016","unstructured":"Mooranian A, Negrulj R, Al-Salami H. The influence of stabilized deconjugated ursodeoxycholic acid on polymer-hydrogel system of transplantable NIT-1 cells. Pharm Res. 2016;33(5):1182\u201390.","journal-title":"Pharm Res"},{"issue":"12","key":"1127_CR42","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/marc.200900901","volume":"31","author":"J Yang","year":"2010","unstructured":"Yang J, Gao C. Fabrication of diverse microcapsule arrays of high density and good stability. Macromol Rapid Commun. 2010;31(12):1065\u201370.","journal-title":"Macromol Rapid Commun"},{"issue":"5","key":"1127_CR43","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/mabi.201300474","volume":"14","author":"G Zheng","year":"2014","unstructured":"Zheng G, Liu X, Wang X, Chen L, Xie H, Wang F, et al. Improving stability and biocompatibility of alginate\/chitosan microcapsule by fabricating bi-functional membrane. Macromol Biosci. 2014;14(5):655\u201366.","journal-title":"Macromol Biosci"},{"issue":"8","key":"1127_CR44","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3109\/02652048.2014.918666","volume":"31","author":"AK De","year":"2014","unstructured":"De AK, Sana S, Datta S, Mukherjee A. Protective efficacy of ursodeoxycholic acid nanoparticles in animal model of inflammatory bowel disease. J Microencapsul. 2014;31(8):725\u201337.","journal-title":"J Microencapsul"},{"issue":"1","key":"1127_CR45","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/BF03191383","volume":"34","author":"H Al-Salami","year":"2009","unstructured":"Al-Salami H, Butt G, Tucker I, Fawcett PJ, Golocorbin-Kon S, Mikov I, et al. Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats. Eur J Drug Metab Pharmacokinet. 2009;34(1):43\u201350.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"12","key":"1127_CR46","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1172\/JCI1325","volume":"101","author":"CM Rodrigues","year":"1998","unstructured":"Rodrigues CM, Fan G, Ma X, Kren BT, Steer CJ. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest. 1998;101(12):2790\u20139.","journal-title":"J Clin Invest"},{"issue":"3","key":"1127_CR47","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF03401914","volume":"4","author":"C Rodrigues","year":"1998","unstructured":"Rodrigues C, Fan G, Wong PY, Kren BT, Steer CJ. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med. 1998;4(3):165\u201378.","journal-title":"Mol Med"},{"issue":"1","key":"1127_CR48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/BF03190984","volume":"32","author":"M Mikov","year":"2007","unstructured":"Mikov M, Boni N, Al-Salami H, Kuhajda K, Kevresan S, Golocorbin-Kon S, et al. Bioavailability and hypoglycemic activity of the semisynthetic bile acid salt, sodium 3\u03b1, 7\u03b1-dihydroxy-12-0X0-5\u03b2-cholanate, in healthy and diabetic rats. Eur J Drug Metab Pharmacokinet. 2007;32(1):7\u201312.","journal-title":"Eur J Drug Metab Pharmacokinet"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-018-1127-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-018-1127-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-018-1127-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T20:13:21Z","timestamp":1720469601000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-018-1127-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,30]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1127"],"URL":"https:\/\/doi.org\/10.1208\/s12249-018-1127-8","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,30]]},"assertion":[{"value":"18 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}